{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:22:06Z","timestamp":1793924526832,"version":"4.8.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1001\/jamadermatol.2020.0796","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T15:31:24Z","timestamp":1587569484000},"page":"659","source":"Crossref","is-referenced-by-count":149,"title":["Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis"],"prefix":"10.1001","volume":"156","author":[{"given":"Aaron M.","family":"Drucker","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Women\u2019s College Research Institute, Department of Medicine, Women\u2019s College Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra G.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Center for Evidence Synthesis in Health, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Bohdanowicz","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Mashayekhi","sequence":"additional","affiliation":[{"name":"Unit for Population-Based Dermatology Research, St John\u2019s Institute of Dermatology, St Thomas\u2019 Hospital, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenas Z. N.","family":"Yiu","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Departments of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Di Giorgio","sequence":"additional","affiliation":[{"name":"Libraries & Collections, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd W. M.","family":"Arents","sequence":"additional","affiliation":[{"name":"Dutch Association for People With Atopic Dermatitis, Nijkerk, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Burton","sequence":"additional","affiliation":[{"name":"Patient Representative (independent), Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis I.","family":"Spuls","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"K\u00fcster","sequence":"additional","affiliation":[{"name":"Center for Evidence-Based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Siegels","sequence":"additional","affiliation":[{"name":"Center for Evidence-Based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Center for Evidence-Based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[{"name":"Unit for Population-Based Dermatology Research, St John\u2019s Institute of Dermatology, St Thomas\u2019 Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200018r1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/DER.0000000000000034","article-title":"Associations of childhood eczema severity: a US population-based study.","volume":"25","author":"Silverberg","year":"2014","journal-title":"Dermatitis"},{"issue":"6","key":"doi200018r2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.2018.73.issue-6","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey.","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"doi200018r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/all.2014.69.issue-1","article-title":"New insights into the epidemiology of childhood atopic dermatitis.","volume":"69","author":"Flohr","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"doi200018r4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3: management and treatment with phototherapy and systemic agents.","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200018r5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/bjd.15235","article-title":"Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists.","volume":"176","author":"Taylor","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi200018r6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaci.2017.07.006","article-title":"Therapeutic pipeline for atopic dermatitis: end of the drought?","volume":"140","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"doi200018r7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2013.07.049","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.","volume":"133","author":"Roekevisch","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"doi200018r8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of English-language restriction on systematic review\u2013based meta-analyses: a systematic review of empirical studies.","volume":"28","author":"Morrison","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"doi200018r9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","article-title":"The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.","volume":"134","author":"Schmitt","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"doi200018r10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/bjd.15179","article-title":"Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.","volume":"176","author":"Spuls","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi200018r11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/ced.1994.19.issue-3","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use.","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"doi200018r15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"6","key":"doi200018r16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/sim.v34.6","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in bayesian meta-analysis.","volume":"34","author":"Turner","year":"2015","journal-title":"Stat Med"},{"issue":"9","key":"doi200018r17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002127","article-title":"Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review.","volume":"13","author":"Golder","year":"2016","journal-title":"PLoS Med"},{"issue":"7-8","key":"doi200018r18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis.","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"1","key":"doi200018r19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data.","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"issue":"1","key":"doi200018r20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/all.2011.67.issue-1","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference.","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"},{"issue":"4","key":"doi200018r21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.v181.4","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"issue":"9","key":"doi200018r22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/all.2012.67.issue-9","article-title":"Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.","volume":"67","author":"Schmitt","year":"2012","journal-title":"Allergy"},{"issue":"2","key":"doi200018r24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"doi200018r25","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"doi200018r26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis.","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"doi200018r27","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"issue":"8","key":"doi200018r28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023061","article-title":"Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis.","volume":"8","author":"Drucker","year":"2018","journal-title":"BMJ Open"},{"key":"doi200018r29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jclinepi.2018.12.008","article-title":"Living network meta-analysis was feasible when considering the pace of evidence generation.","volume":"108","author":"Cr\u00e9quit","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"doi200018r30","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis.","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"doi200018r31","article-title":"Effects of upadacitinib on atopic dermatitis signs, symptoms and patient-reported outcomes from a phase IIb randomized, placebo-controlled trial","volume":"179","author":"De Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"doi200018r32","first-page":"76","article-title":"Early response to upadacitinib in moderate-to-severe atopic dermatitis: results from a phase 2b randomized, placebo-controlled trial","volume":"73","author":"Reich","year":"2018","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"4","key":"doi200018r34","doi-asserted-by":"crossref","first-page":"AB195","DOI":"10.1016\/j.jaad.2019.06.722","article-title":"Dupilumab for adolescents with moderate-to-severe atopic dermatitis: results from a phase 3, randomized, double-blinded trial.","volume":"81","author":"Paller","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200018r36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE).","volume":"78","author":"Simpson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200018r37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial.","volume":"78","author":"Guttman-Yassky","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200018r38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"doi200018r39","article-title":"Systemic treatments for eczema: a network meta-analysis.","author":"Sawangjit","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"doi200018r12","author":"Higgins"},{"key":"doi200018r14"},{"key":"doi200018r23","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd ed"},{"key":"doi200018r13","unstructured":"Mitchell? M, Muftakhidinov? B, Winchen? T. Engauge Digitizer. Published 2019. Accessed March 21, 2019. http:\/\/markummitchell.github.io\/engauge-digitizer"},{"key":"doi200018r33","unstructured":"ClinicalTrials.gov. Efficacy and safety of dupilumab in participants =12 to <18 years of age, with moderate-to-severe atopic dermatitis. Accessed October 28, 2019. https:\/\/ClinicalTrials.gov\/show\/NCT03054428"},{"key":"doi200018r35","unstructured":"ClinicalTrials.gov. efficacy and safety study of QAW039 in the treatment of patients with moderate to severe atopic dermatitis. Accessed March 21, 2019. https:\/\/ClinicalTrials.gov\/show\/NCT01785602"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2765026\/jamadermatology_drucker_2020_oi_200018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T17:43:08Z","timestamp":1591810988000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2765026"}},"subtitle":["A Systematic Review and Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0796","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}